These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 26228271)
1. Two-photon microscopy of a Flt1 peptide-hyaluronate conjugate. Beack S; Choi JS; Lee JH; Kim H; Kim KH; Joo CK; Hahn SK Nanomedicine (Lond); 2015; 10(15):2315-24. PubMed ID: 26228271 [TBL] [Abstract][Full Text] [Related]
2. Flt1 peptide-hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization. Kim H; Choi JS; Kim KS; Yang JA; Joo CK; Hahn SK Acta Biomater; 2012 Nov; 8(11):3932-40. PubMed ID: 22824530 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization, and preliminary assessment of anti-Flt1 peptide-hyaluronate conjugate for the treatment of corneal neovascularization. Oh EJ; Park K; Choi JS; Joo CK; Hahn SK Biomaterials; 2009 Oct; 30(30):6026-34. PubMed ID: 19647313 [TBL] [Abstract][Full Text] [Related]
4. Anti-Flt1 peptide - hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy. Oh EJ; Choi JS; Kim H; Joo CK; Hahn SK Biomaterials; 2011 Apr; 32(11):3115-23. PubMed ID: 21277020 [TBL] [Abstract][Full Text] [Related]
5. Bioimaging and pulmonary applications of self-assembled Flt1 peptide-hyaluronic acid conjugate nanoparticles. Kim H; Park HT; Tae YM; Kong WH; Sung DK; Hwang BW; Kim KS; Kim YK; Hahn SK Biomaterials; 2013 Nov; 34(33):8478-90. PubMed ID: 23932502 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Lai CM; Brankov M; Zaknich T; Lai YK; Shen WY; Constable IJ; Kovesdi I; Rakoczy PE Hum Gene Ther; 2001 Jul; 12(10):1299-310. PubMed ID: 11440623 [TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of corneal neovascularization: comparison of different doses of subconjunctival bevacizumab with corticosteroid in experimental rats. Hashemian MN; Moghimi S; Kiumehr S; Riazi M; Amoli FA Ophthalmic Res; 2009; 42(2):90-5. PubMed ID: 19546599 [TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease. Lee D; Lu Q; Sommerfeld SD; Chan A; Menon NG; Schmidt TA; Elisseeff JH; Singh A Acta Biomater; 2017 Jun; 55():163-171. PubMed ID: 28363785 [TBL] [Abstract][Full Text] [Related]
9. Nose-to-brain delivery of hyaluronate - FG loop peptide conjugate for non-invasive hypoxic-ischemic encephalopathy therapy. Kim YS; Sung DK; Kim H; Kong WH; Kim YE; Hahn SK J Control Release; 2019 Aug; 307():76-89. PubMed ID: 31229472 [TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-endostatin2-alft1 (HA-ES2-AF) nanoparticle-like conjugate for the target treatment of diseases. Sun F; Yu Y; Yang Z; Wang Z; Li Y; Wang F; Tan H J Control Release; 2018 Oct; 288():1-13. PubMed ID: 30170067 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronate - parathyroid hormone peptide conjugate for transdermal treatment of osteoporosis. Cho M; Han S; Kim H; Kim KS; Hahn SK J Biomater Sci Polym Ed; 2018; 29(7-9):793-804. PubMed ID: 29115187 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Pathologic Corneal Neovascularization by Topical Application of a Novel Peptide In Vivo. Lu Y; Xu Y; Gu Q; Xu X Cornea; 2015 Oct; 34(10):1295-302. PubMed ID: 26266428 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of chemical cautery-induced corneal neovascularization by topical pigment epithelium-derived factor eyedrops. Jin J; Ma JX; Guan M; Yao K Cornea; 2010 Sep; 29(9):1055-61. PubMed ID: 20539216 [TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effect of KR-31831 on corneal and choroidal neovascularization in rat models. Kim IT; Park HY; Choi JS; Joo CK Invest Ophthalmol Vis Sci; 2012 May; 53(6):3111-9. PubMed ID: 22491414 [TBL] [Abstract][Full Text] [Related]
17. Target specific hyaluronic acid-interferon alpha conjugate for the treatment of hepatitis C virus infection. Yang JA; Park K; Jung H; Kim H; Hong SW; Yoon SK; Hahn SK Biomaterials; 2011 Nov; 32(33):8722-9. PubMed ID: 21872329 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity. Lee H; Lee K; Park TG Bioconjug Chem; 2008 Jun; 19(6):1319-25. PubMed ID: 18481885 [TBL] [Abstract][Full Text] [Related]
19. Topical and subconjunctival bevacizumab for corneal neovascularization in an experimental rat model. Öner V; Küçükerdönmez C; Akova YA; Çolak A; Karalezli A Ophthalmic Res; 2012; 48(3):118-23. PubMed ID: 22538642 [TBL] [Abstract][Full Text] [Related]
20. Transdermal delivery of hyaluronic acid -- human growth hormone conjugate. Yang JA; Kim ES; Kwon JH; Kim H; Shin JH; Yun SH; Choi KY; Hahn SK Biomaterials; 2012 Sep; 33(25):5947-54. PubMed ID: 22632765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]